No abstract available
MeSH terms
-
Acute Kidney Injury / complications
-
Betacoronavirus*
-
Blood Coagulation Disorders / blood*
-
Blood Coagulation Disorders / drug therapy
-
Blood Coagulation Disorders / physiopathology
-
COVID-19
-
Comorbidity
-
Coronavirus Infections / blood*
-
Coronavirus Infections / complications
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / physiopathology
-
Factor Xa Inhibitors / therapeutic use
-
Fibrin Fibrinogen Degradation Products / analysis
-
Fibrinolytic Agents / therapeutic use
-
Hemostasis
-
Heparin / therapeutic use
-
Humans
-
Italy
-
Pandemics
-
Pneumonia, Viral / blood*
-
Pneumonia, Viral / complications
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / physiopathology
-
Pulmonary Embolism / blood
-
Pulmonary Embolism / etiology
-
Pulmonary Embolism / prevention & control
-
SARS-CoV-2
-
Societies, Medical
-
Thrombosis / blood
-
Thrombosis / drug therapy
Substances
-
Factor Xa Inhibitors
-
Fibrin Fibrinogen Degradation Products
-
Fibrinolytic Agents
-
fibrin fragment D
-
Heparin